Incyte director granted RSUs and stock options

INCYTE CORP director Katherine A. High reported equity compensation awards rather than open-market trading.

Rhea-AI Filing Summary

INCYTE CORP director Katherine A. High reported equity compensation awards rather than open-market trading. She received 1,642 restricted stock units that each convert into one share of common stock, and these RSUs vest in full on the first anniversary of the grant, or earlier if the next regular annual stockholders’ meeting or a change of control occurs.

She was also granted a non-qualified stock option covering 6,111 shares of common stock at an exercise price of $100.64 per share, vesting on the same schedule and expiring in 2036. Following these awards, she directly holds 14,983 shares of common stock, plus the new option grant.

Insider Trade Summary

Grant/Award: 7,753 shares

Grant/Award 2 txns

Insider High Katherine A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Non Qualfied Stock Option (right to buy)	6,111	$0.00	$0.00
Grant/Award	Common Stock	1,642	$0.00	$0.00

Holdings After Transaction: Non Qualfied Stock Option (right to buy) — 6,111 contracts (Direct); Common Stock — 14,983 shares (Direct)

Footnotes (3)

1. F1. This award of restricted stock units ("RSUs") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis.
2. F2. Including this grant, this includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
3. F3. This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan).

Key Figures

RSU grant: 1,642 RSUs Option grant size: 6,111 options Option exercise price: $100.64 per share +2 more

5 metrics

RSU grant 1,642 RSUs Award of restricted stock units on June 8, 2026

Option grant size 6,111 options Non-qualified stock option covering 6,111 shares

Option exercise price $100.64 per share Exercise price for non-qualified stock option

Option expiration 2036-06-07 Expiration date of the non-qualified stock option

Shares after transaction 14,983 shares Total common shares directly held after grants

Key Terms

restricted stock units ("RSUs"), Non Qualfied Stock Option (right to buy), change of control, annual meeting of the Company's stockholders

4 terms

restricted stock units ("RSUs") financial

"This award of restricted stock units ("RSUs") vests in full on the first anniversary..."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Non Qualfied Stock Option (right to buy) financial

"Non Qualfied Stock Option (right to buy)"

change of control financial

"or upon a change of control (as defined in the RSU plan)."

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

annual meeting of the Company's stockholders financial

"or, if earlier, the date of the next regular annual meeting of the Company's stockholders..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did INCYTE (INCY) director Katherine A. High report?

Katherine A. High reported equity compensation grants, not market trades. She received 1,642 restricted stock units and a non-qualified stock option for 6,111 shares, both awarded on June 8, 2026 with future vesting conditions.

How many INCYTE (INCY) restricted stock units did the director receive?

She received 1,642 restricted stock units (RSUs). Each RSU can be settled for one share of common stock. The award vests in full on the first anniversary of the grant, or earlier upon the next regular annual stockholders’ meeting or a qualifying change of control.

What are the terms of the INCYTE (INCY) stock options granted to the director?

She was granted a non-qualified stock option for 6,111 shares of common stock at an exercise price of $100.64 per share. The option vests in full after about one year or earlier upon specified corporate events and expires in 2036.

How many INCYTE (INCY) shares does Katherine A. High hold after these grants?

After the reported grants, she directly holds 14,983 shares of INCYTE common stock. This share count reflects her position following the RSU-related common stock entry in the filing, in addition to the newly awarded stock option for 6,111 underlying shares.

Do the INCYTE (INCY) Form 4 transactions involve open-market buying or selling?

No, the Form 4 reflects grant or award acquisitions, not open-market trades. Both the 1,642 RSUs and the 6,111-share option were awarded at a reported price of $0.00 per share as part of director compensation, with no buy or sell codes indicated.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

High Katherine A

(Last) (First) (Middle)

1801 AUGUSTINE CUTOFF

(Street)

WILMINGTON DELAWARE 19803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/08/2026		A		1,642(1)	A	$0	14,983(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non Qualfied Stock Option (right to buy)	$100.64	06/08/2026		A		6,111		(3)	06/07/2036	Common Stock	6,111	$0	6,111	D

Explanation of Responses:

1. This award of restricted stock units ("RSUs") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis.

2. Including this grant, this includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

3. This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan).

Remarks:

	/s/ Elizabeth Feeney, Attorney-In-Fact	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)